These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2896669)

  • 1. Evaluation of in vitro methods for testing ceftriaxone against anaerobic bacteria, including quality control guidelines.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Apr; 26(4):776-7. PubMed ID: 2896669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality control guidelines for testing cefotetan in the reference agar dilution procedure for susceptibility testing of anaerobic bacteria.
    Zabransky RJ; Bobey DG; Barry AL; Allen SD; Fuchs PC; Gerlach EH; Thornsberry C; Sheikh W; Jones RN
    J Clin Microbiol; 1989 Jan; 27(1):190-1. PubMed ID: 2643621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control criteria for testing the susceptibility of anaerobic bacteria to meropenem.
    Zabransky RJ; Bayola-Mueller L; Jenkins SG; Pitkin DR; Schreckenberger PC; Celig DM; Spiegel CA
    J Clin Microbiol; 1990 Dec; 28(12):2804-5. PubMed ID: 2280013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of agar dilution, microdilution, and disk elution methods for measuring the synergy of cefotaxime and its metabolite against anaerobes.
    Smith JA; Henry D; Ngui-Yen J; Castell A; Coderre S
    J Clin Microbiol; 1986 Jun; 23(6):1104-8. PubMed ID: 2872231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species.
    Kronvall G; Holst E
    Clin Microbiol Infect; 2000 Apr; 6(4):195-201. PubMed ID: 11168107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination.
    Barry AL; Jones RN
    J Clin Microbiol; 1988 Jan; 26(1):13-7. PubMed ID: 3343304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of MICs of moxalactam for control and reference anaerobic organisms in agar dilution and microdilution techniques.
    Sutter VL; Emmerman J; Randall E; Zabransky RJ; Birk RJ
    Antimicrob Agents Chemother; 1985 Mar; 27(3):424-6. PubMed ID: 3888103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.
    Jones RN; Gavan TL; Thornsberry C; Fuchs PC; Gerlach EH; Knapp JS; Murray P; Washington JA
    J Clin Microbiol; 1989 Dec; 27(12):2758-66. PubMed ID: 2531756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ceftizoxime and cefoxitin susceptibility testing against anaerobic bacteria: comparison of results from three NCCLS methods and quality control recommendations for the reference agar dilution procedure.
    Jones RN; Barry AL; Fuchs PC; Allen SD
    Diagn Microbiol Infect Dis; 1987 Oct; 8(2):87-94. PubMed ID: 3480787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of three long-acting cephalosporins against Bacteroides fragilis, Peptostreptococcus species and Clostridium perfringens.
    Watt B; Naden MG
    Chemioterapia; 1988 Aug; 7(4):264-6. PubMed ID: 2902937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broth-disk elution tests to predict the susceptibility of anaerobic bacteria to the ampicillin-sulbactam combination.
    Jones RN
    Diagn Microbiol Infect Dis; 1990; 13(4):353-5. PubMed ID: 2076598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of broth microdilution susceptibility results for anaerobic organisms by use of a rapid direct colony inoculum.
    Mangels JI; Lindberg LH
    J Clin Microbiol; 1985 Feb; 21(2):269-72. PubMed ID: 3972999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics.
    Jorgensen JH; Redding JS; Howell AW
    J Clin Microbiol; 1986 Mar; 23(3):545-50. PubMed ID: 3514661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting the susceptibility of anaerobes to cefoperazone, cefotaxime, and cefoxitin with the thioglycolate broth disk procedure.
    Zabransky RJ; Birk RJ; Kurzynski TA; Toohey KL
    J Clin Microbiol; 1986 Aug; 24(2):181-5. PubMed ID: 3745418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of susceptibility of anaerobic bacteria to cefotetan and cefoxitin by the thioglycolate disk elution method.
    Barry AL; Packer RR
    J Clin Microbiol; 1984 Nov; 20(5):912-6. PubMed ID: 6595259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of anaerobic bacteria isolated in Johannesburg.
    van der Westhuyzen I; Chalkley LJ
    S Afr Med J; 1992 Nov; 82(5):314-7. PubMed ID: 1448710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility testing of anaerobic bacteria.
    Finegold SM; Rolfe RD
    Diagn Microbiol Infect Dis; 1983 Mar; 1(1):33-40. PubMed ID: 6323094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased in vitro activity of ceftriaxone by addition of tazobactam against clinical isolates of anaerobes.
    Aldridge KE; Morice N; Schiro DD
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):227-34. PubMed ID: 7851086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
    Jones RN; Barry AL; Aldridge KE; Gerlach EH
    Diagn Microbiol Infect Dis; 1987 Nov; 8(3):157-63. PubMed ID: 3501976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activity of ceftriaxone on hospital bacteria. Results of a multicenter study].
    Soussy CJ; Deforges L; Le Van Thoi J; Chanal M; Sirot D; Acar JF; Kitzis MD; Thabaut A; Meyran M; Dabernat H
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):469-72. PubMed ID: 2868442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.